Kidney Care Partners

What Kidney Care Partners does

Kidney Care Partners (KCP) is a non-profit advocacy coalition founded in May 2003 and headquartered in Washington, DC. The organization comprises more than 30 member organizations representing the full kidney care continuum—patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers—and operates as the nation's largest kidney care coalition. Its core function is federal policy advocacy directed at CMS and Congress on issues including ESRD payment rules, Medicare reimbursement, transplant access, and innovation pathways, alongside quality improvement initiatives such as the PEAK program (launched 2009, which demonstrated a 25% reduction in 90-day mortality and 13.6% reduction in first-year mortality for dialysis patients) and educational content including a multi-episode Kidney Disease Docuseries.

KCP does not offer commercial products or services; it is funded through membership dues from its coalition partners, including major dialysis providers (DaVita, Fresenius Medical Care North America), patient advocacy organizations (American Kidney Fund, National Kidney Foundation, Dialysis Patient Citizens, Renal Support Network), professional societies (American Society of Nephrology, American Nephrology Nurses Association), and therapeutic innovators (AstraZeneca, Akebia Therapeutics, Novartis, CSL Vifor). The organization serves the interests of approximately 37 million Americans living with chronic kidney disease, over 500,000 on dialysis, more than 700,000 with end-stage renal disease, and 97,000+ awaiting transplant.

The coalition is governed by an elected Chair and an executive team led by Executive Director Colin Roskey, with Chair-Elect Dr. Keith A. Bellovich assuming the chair role in December 2025 succeeding LaVarne Burton. Operations and membership are managed by Christine Walizer. The entity is structured as a 501(c)(4) non-profit with no parent company, no subsidiaries, no funding rounds, and no investor ownership; its strategic posture is defined by sustained engagement with federal regulators, expansion of disease-specific advocacy sub-verticals (notably APOL1-Mediated Kidney Disease), and coalition-building across the kidney care ecosystem.

Name

Kidney Care Partners

Legal name

Kidney Care Partners

Website

https://kidneycarepartners.org

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

Kidney Care Partners is a non-profit advocacy coalition of 30+ organizations—patients, providers, physicians, researchers, and manufacturers—that conducts federal policy advocacy, quality improvement, and public education on behalf of Americans with chronic kidney disease and end-stage renal disease.

Ownership category

akta.pro rank

Product category

Healthcare Advocacy

NAICS

Social Advocacy Organizations (8133), Voluntary Health Organizations (813212)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Patient Advocacy, Navigation & Access to Care (BPAGACAH)

akta.pro secondary industries

Public Health & Health Equity Organizations (BPAGACAL), Outpatient Dialysis & Kidney Care Centers (HLAFABAE)

Keywords

• Kidney disease advocacy
• Healthcare policy coalition
• Dialysis care advocacy
• Nephrology policy reform
• Chronic kidney disease education

Headquarters

HQ city

Alexandria

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Distribution channels1 record

Marketing channels5 records

Core offering

Kidney Care Partners is a non-profit advocacy coalition that brings together more than 30 organizations across the kidney care continuum — patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers — to advocate before Congress and CMS for policies that improve care coordination, expand treatment access, advance research, and reform kidney care economics. The coalition runs quality improvement initiatives such as the PEAK program and produces educational content including a multi-episode docuseries on chronic kidney disease.

Product overview

Kidney Care Partners is a non-profit healthcare advocacy coalition, not a product company. KCP does not offer commercial products or services; instead, it operates as a coalition of over 30 organizations including patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers. The organization's primary activities include policy advocacy, quality improvement initiatives (such as the PEAK quality initiative), legislative agenda work, and educational programs including a docuseries about kidney disease. All outputs are informational/advocacy in nature rather than commercial technology products.

Differentiator

Problem solved

Functional benefit

Products and services

• PEAK (Performance Excellence and Accountability in Kidney Care) Quality Initiative A voluntary community initiative designed to highlight proven clinical practices with the goal of improving the rate of survival of kidney failure patients new to dialysis. Focused on reducing catheter use, improving cardiovascular outcomes, managing nutrition and inflammation, handling anemia, and optimizing dialysis. The initiative achieved a 25% reduction in 90-day mortality rates and a 13.6% reduction in first-year mortality rates for dialysis patients.
• Policy Advocacy Services Coalition-driven advocacy before Congress, CMS, and federal health agencies aimed at improving coordination of care and understanding of chronic kidney disease, lowering barriers to patient access to treatments, expanding research efforts, and reforming kidney care economics. Services include formal regulatory comments (e.g., CMS ESRD PPS proposals), congressional advocacy days, and stakeholder engagement.
• Kidney Disease Docuseries An eight-episode educational docuseries revealing the human side of kidney disease through the everyday experiences of patients, doctors, nurses, and care partners navigating a complex healthcare system. Episodes cover chronic kidney disease basics, patient demographics, economics of kidney disease, transplant access, dialysis center operations, delaying dialysis, health equity, and home dialysis.
• KCP Blog An informational blog covering topics including kidney care quality, Medicare ESRD PPS rules, home dialysis, transplant access, patient safety, and mental health for individuals with chronic kidney disease. Published on the KCP website to inform stakeholders and the public.

Quantifiable outcome

• 25% reduction in mortality rates for dialysis patients in the first 90 days of treatment
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

29 partnerships are on record, tiered core and secondary.

• American Kidney Fund (AKF)coreStrategic or Co-development PartnerAmerican Kidney Fund is a key member of the KCP coalition and a leader in kidney disease advocacy, financial assistance to patients, and health education. LaVarne Burton serves as both AKF President/CEO and KCP Chairwoman.
• DaVitacoreStrategic or Co-development PartnerDaVita is a major dialysis provider and coalition member, representing the provider perspective in KCP's advocacy for kidney care policy improvements.
• Fresenius Medical Care North AmericacoreStrategic or Co-development PartnerFresenius is a leading dialysis provider and member of KCP, contributing expertise in dialysis care delivery and quality improvement.
• American Nephrology Nurses Association (ANNA)coreStrategic or Co-development PartnerANNA represents nephrology nurses within KCP, providing clinical expertise and advocating for quality care standards.
• American Society of Nephrology (ASN)coreStrategic or Co-development PartnerASN is the professional society for nephrologists and kidney researchers, contributing scientific and clinical expertise to KCP's policy advocacy.
• AstraZenecacoreStrategic or Co-development PartnerAstraZeneca participates as a therapeutic innovator member, contributing expertise in kidney disease treatments and therapies to the coalition.
• Akebia TherapeuticscoreStrategic or Co-development PartnerAkebia is a biopharmaceutical company focused on kidney disease therapeutics, participating as a manufacturer member in KCP.
• The Rogosin InstitutecoreStrategic or Co-development PartnerRogosin is a non-profit kidney care organization and dialysis provider contributing to quality improvement and patient care initiatives.
• Dialysis Patient Citizens (DPC)coreStrategic or Co-development PartnerDPC is a patient-led advocacy organization representing dialysis patients' interests within the KCP coalition.
• Renal Support Network (RSN)coreStrategic or Co-development PartnerRSN is a patient advocacy organization founded by a kidney disease survivor, providing the patient perspective to KCP's advocacy efforts.
• National Kidney Foundation (NKF)coreStrategic or Co-development PartnerNKF is a leading kidney disease organization contributing to KCP's advocacy for patient access and quality care.
• NATCOcoreStrategic or Co-development PartnerNATCO (North American Transplant Coordinators Organization) provides transplant coordination expertise and advocates for organ donation within KCP.
• CorMedixsecondaryStrategic or Co-development PartnerCorMedix is a pharmaceutical company focused on nephrology products, participating as a manufacturer member.
• CSL ViforsecondaryStrategic or Co-development PartnerCSL Vifor is a pharmaceutical company contributing expertise in kidney disease and rare disease therapies to KCP.
• NovartissecondaryStrategic or Co-development PartnerNovartis participates as a pharmaceutical manufacturer member, contributing to KCP's policy discussions on innovative therapies.
• U.S. Renal CaresecondaryStrategic or Co-development PartnerU.S. Renal Care is a dialysis provider organization contributing the provider perspective to KCP.
• American Society of Pediatric Nephrology (ASPN)secondaryStrategic or Co-development PartnerASPN represents pediatric nephrologists, contributing specialized expertise in childhood kidney disease.
• The Kidney CollectivecoreStrategic or Co-development PartnerFounded by LaVarne Burton, The Kidney Collective collaborates with KCP on APOL1-Mediated Kidney Disease (AMKD) awareness initiatives and health disparities advocacy.
• Atlantic DialysissecondaryStrategic or Co-development PartnerAtlantic Dialysis is a dialysis provider organization participating in the KCP coalition.
• DialitysecondaryStrategic or Co-development PartnerDiality is a medical device company developing portable dialysis solutions, participating as a manufacturer member.
• DCC (Dialysis Care Center)secondaryStrategic or Co-development PartnerDCC is a dialysis provider organization contributing to the coalition's provider perspective.
• Greenfield Health SystemssecondaryStrategic or Co-development PartnerGreenfield Health Systems is a dialysis provider organization and coalition member.
• Kidney Care CouncilsecondaryStrategic or Co-development PartnerKidney Care Council is a national health care association of dialysis providers representing the provider perspective.
• National Renal Administrators Association (NRAA)secondaryStrategic or Co-development PartnerNRAA represents renal administrators and dialysis facility operators in KCP's advocacy efforts.
• NNCCsecondaryStrategic or Co-development PartnerNNCC (Nephrology Nursing Certification Commission) contributes expertise in nephrology nursing certification and education.
• Pathalys PharmasecondaryStrategic or Co-development PartnerPathalys Pharma is a pharmaceutical company focused on kidney disease treatments, participating as a manufacturer member.
• Renal Healthcare AssociationsecondaryStrategic or Co-development PartnerThe Renal Healthcare Association represents dialysis providers in KCP's policy advocacy.
• Renal Physicians AssociationsecondaryStrategic or Co-development PartnerRPA represents nephrology physicians and contributes clinical expertise to KCP's advocacy.
• UnicycivesecondaryStrategic or Co-development PartnerUnicycive is a pharmaceutical company developing treatments for kidney disease, participating as a manufacturer member.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• American Heart Association: Major U.S. health nonprofit combining research funding, patient education, and aggressive federal advocacy. Closely comparable organizational structure, advocacy intensity, and quality program methodology (e.g., Get With The Guidelines), with cardiovascular-kidney-metabolic overlap.
• PhRMA: Trade association representing the pharmaceutical industry in federal policy, with comparable convening power, federal lobbying intensity, and member-funded advocacy model. Several of KCP's pharma members (AstraZeneca, Novartis) are also PhRMA members.
• AdvaMed: Medical device industry trade association running federal policy, reimbursement, and market access advocacy. Comparable to KCP's role for the device-and-innovation subset of its coalition (e.g., Diality, CorMedix).
• American Diabetes Association: Large national nonprofit conducting research, education, and federal advocacy for the chronic disease most responsible for kidney failure. Highly comparable operating model—nonprofit, federal advocacy, quality programs, large coalition footprint—with overlapping population and policy agenda.
• American Cancer Society Cancer Action Network: 501(c)(4) advocacy affiliate of the American Cancer Society, operating as a federal lobbying and policy organization for cancer patients. Structurally the closest model to a 501(c)(4) nonprofit health advocacy coalition like KCP.

Direct peers

• Alliance for Home Dialysis: Non-profit coalition dedicated to breaking down barriers to home dialysis, with industry, provider, and patient members. Closely comparable organizational structure to KCP, focused on a specific kidney care policy subset (home modality choice and reimbursement).
• American Society of Nephrology: The premier professional society for nephrologists and kidney researchers, engaging in federal policy advocacy on research funding, reimbursement, and workforce. KCP member but operates an independent advocacy and clinical education portfolio directly comparable in target stakeholders.
• American Kidney Fund: National kidney-focused nonprofit providing direct patient financial assistance, health education, and federal advocacy. AKF is a core KCP member and Chair LaVarne Burton leads both organizations, but operates as an independent comparable advocacy entity.
• National Kidney Foundation: The leading national nonprofit dedicated to kidney disease awareness, prevention, and patient advocacy. Despite also being a KCP member, NKF is independently comparable in mission and federal advocacy footprint, targeting the same CKD/ESRD patient population.
• Dialysis Patient Citizens: Patient-led advocacy organization representing dialysis patients in federal policy. KCP coalition member but independently operates comparable federal advocacy, congressional engagement, and patient mobilization programs targeting the same ESRD population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/kcp_tweets
• Facebookfacebook.com/kidneycarepartners
• LinkedInlinkedin.com/company/kidney-care-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kidney Care Partners